ADMT vs RPM vs BSX Stock Comparison

Adm Tronics Unlimited, Rpm International and Boston Scientific Prices as of Nov 5, 2026 Peers: Industry group
1 more company in this comparison (EW) Create a free account to keep reading and compare up to 10 companies.
RPM Rpm International Inc/De/
$105.33 +7.1% 1M -2.1% 1Y
Market cap
$13.19B
P/E
19.1x
Revenue (TTM)
$7.97B
Div. yield
–
Paints and Coatings Basic Materials
3 wins
BSX Boston Scientific Corp
$44.62 +5.8% 1M -54.9% 1Y
Market cap
$62.89B
P/E
18.0x
Revenue (TTM)
$21.07B
Div. yield
–
Medical Devices Healthcare
6 wins

Head to Head

11 decided of 12

Boston Scientific leads on 6 of the 12 questions below (Boston Scientific 6, Rpm International 3, Adm Tronics Unlimited 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionADMTRPMBSXLeader
Larger companyMarket capitalisation $6.93M $13.19B $62.89B BSX
Cheaper on earningsLower P/E, profitable companies only -17.5x 19.1x 18.0x BSX
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 18.9x 14.6x BSX
Faster revenue growthRevenue growth, trailing twelve months -2.2% +6.0% +8.9% BSX
More profitableNet margin, trailing twelve months -12.2% 8.7% 16.6% BSX
Better return on capitalReturn on invested capital -27.1% 12.5% 9.9% RPM
Less leveragedLower net debt / EBITDA -0.9x 1.8x 2.1x ADMT
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months 0.0% -2.1% -54.9% ADMT
Better 5-year returnAnnualised price return, 5 years -3.9%/yr +3.2%/yr +0.7%/yr RPM
Less volatileAnnualised volatility, 1 year 188.1% 30.7% 41.2% RPM
Higher overall scoreMean of the five percentile scores vs peers 28/100 60/100 67/100 BSX

Percentile Scorecard

ADMTRPMBSX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisADMTRPMBSX
Valuation 46 #125 of 229 49 #49 of 95 88 #29 of 229
Growth 2 #217 of 221 59 #39 of 93 67 #73 of 221
Profitability 46 #113 of 210 85 #14 of 89 90 #21 of 210
Financial Health 16 #201 of 240 54 #45 of 96 45 #132 of 240
Shareholder Returns – 54 #35 of 75 46 #80 of 147
Overall 28 60 67
  • ADMT ranked among 247 companies in Medical Devices and Diagnostics
  • RPM ranked among 99 companies in Chemicals
  • BSX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodADMTRPMBSXSPY
1 month +80.0%+7.1%+5.8% -5.9%
3 months +125.0%-8.9%-9.5% -4.6%
6 months +12.5%+3.9%-21.1% +0.2%
Year to date -10.0%+1.3%-53.2% +7.5%
1 year 0.0%-2.1%-54.9% +8.2%
3 years -18.2%+9.5%-15.5% +68.3%
3 years, per year -6.5%+3.1%-5.5% +19.0%
5 years -18.2%+17.3%+3.4% +56.5%
5 years, per year -3.9%+3.2%+0.7% +9.4%
10 years -52.6%+123.5%+107.0% +251.5%
10 years, per year -7.2%+8.4%+7.5% +13.4%

Risk

MeasureADMTRPMBSXSPY
Volatility, 1Y 188.1%30.7%41.2% 13.6%
Downside volatility, 1Y 353.6%26.8%47.6% 14.2%
Beta vs S&P 500, 1Y -1.640.920.22 1.00
Return / volatility, 1Y 0.00-0.07-1.33 0.60
Max drawdown, 5Y -80.0%-33.5%-61.6% -25.4%
From 52-week high -25.0%-12.3%-57.5% -5.9%
52-week high $0.12$120.17$104.98 $779.14
52-week low $0.03$93.23$41.57 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleADMTRPMBSX
P/E now vs peer median -15.4xmedian 26.9x 19.3xmedian 21.2x 18.5xmedian 26.9x
P/S now vs peer median 1.9xmedian 2.9x 1.7xmedian 1.3x 3.1xmedian 2.9x
EV/EBITDA now vs peer median -24.3xmedian 17.5x 13.2xmedian 11.7x 14.2xmedian 17.5x
P/FCF now vs peer median -38.7xmedian 26.4x 19.0xmedian 17.0x 19.4xmedian 26.4x
P/B now vs peer median 10.1xmedian 2.3x 3.9xmedian 1.5x 2.5xmedian 2.3x
PEG now vs peer median 0.55median 0.88 1.76median 1.76 0.42median 0.88

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsADMTRPMBSX
Revenue $3.24M $7.97B $21.07B
Gross profit $1.27M $3.28B $14.57B
Operating income -$288.99K $961.65M $3.93B
Net income -$395.64K $691.27M $3.49B
Free cash flow -$157.02K $705.58M $3.33B
R&D $522.65K – $2.16B
EPS (diluted) $-0.01 $5.42 $2.41
Cash & equivalents $222.62K $312.84M $609.00M
Total debt $448.85K $2.41B $11.95B
Shares (diluted) 67.59M 127.24M 1.45B
Enterprise value $5.83M $11.95B $58.32B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricADMTRPMBSX
P/E -15.4x 19.3x 18.5x
P/FCF -38.7x 19.0x 19.4x
P/Operating cash flow -38.7x 14.5x 15.3x
P/S 1.9x 1.7x 3.1x
P/B 10.1x 3.9x 2.5x
P/Tangible book 10.2x 5.0x 3.4x
EV/EBITDA -24.3x 13.2x 14.2x
EV/EBIT -21.8x 16.1x 19.3x
EV/Revenue 1.9x 1.9x 3.6x
EV/FCF -40.2x 22.0x 22.8x
EV/Operating cash flow -40.2x 16.8x 18.0x
PEG (3Y EPS CAGR) 0.55 1.76 0.42

Growth

14 metrics
MetricADMTRPMBSX
Revenue growth (1Y) -2.2% 6.0% 8.9%
Revenue CAGR (3Y) -2.7% 2.8% 15.3%
Gross profit growth (1Y) -6.4% 5.5% 9.8%
Gross profit CAGR (3Y) -7.4% 5.0% 15.1%
Operating income growth (1Y) -93.9% 9.0% 13.5%
Operating income CAGR (3Y) -58.3% 5.9% 22.1%
Net income growth (1Y) -485.4% 0.2% 25.5%
Net income CAGR (3Y) -27.7% 10.5% 41.7%
EPS growth (1Y) -485.4% 0.8% 29.2%
EPS CAGR (3Y) -27.7% 11.0% 44.0%
Operating cash flow growth (1Y) -389.0% 22.1% -8.5%
Operating cash flow CAGR (3Y) -84.7% 0.4% 21.6%
Free cash flow growth (1Y) -389.0% 36.7% -12.9%
Free cash flow CAGR (3Y) -84.7% 2.0% 25.2%

Profitability

14 metrics
MetricADMTRPMBSX
Gross margin 39.2% 41.2% 69.1%
EBITDA margin -8.0% 14.8% 25.5%
Operating margin -8.9% 12.1% 18.7%
Pretax margin -12.2% 11.4% 17.3%
Net margin -12.2% 8.7% 16.6%
FCF margin -4.8% 8.9% 15.8%
Operating cash flow margin -4.8% 11.6% 20.1%
Return on equity -67.4% 20.4% 13.7%
Return on assets -20.6% 8.3% 7.7%
Return on invested capital -27.1% 12.5% 9.9%
Return on capital employed -41.9% 15.1% 10.0%
Asset turnover 1.7x 1.0x 0.5x
Cash conversion (OCF / net income) 0.4x 1.3x 1.2x
Stock comp / revenue – 0.5% 1.5%

Financial Health

11 metrics
MetricADMTRPMBSX
Debt / assets 22.2% 29.2% 26.3%
Debt / equity 0.7x 0.7x 0.5x
Net debt / EBITDA -0.9x 1.8x 2.1x
Debt / FCF -2.9x 3.4x 3.6x
Liabilities / assets 70.2% 57.7% 43.1%
Equity / assets 29.8% 42.3% 56.9%
Interest coverage -8.0x 8.9x 10.5x
Current ratio 1.0x 1.8x 1.4x
Quick ratio 0.7x 1.0x 0.6x
Cash ratio 0.2x 0.2x 0.1x
Altman Z-score -19.20 3.90 3.05

Shareholder Returns

7 metrics
MetricADMTRPMBSX
Dividend yield – 2.1% –
Net buyback yield – 0.6% -0.3%
Shareholder yield – 2.7% -0.3%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusADMTRPMBSX
Forward P/E – 18.9xFY2026 14.6xFY2026
EPS, next fiscal year – $5.58FY2026 $3.06FY2026
EPS growth, next FY – +0.9%FY2026 0.0%FY2026
EPS growth, the year after – +12.5% +8.5%
Revenue, next fiscal year – $7.69BFY2026 $20.49BFY2026
Revenue growth, next FY – -2.1%FY2026 +2.1%FY2026
Revenue growth, the year after – +8.0% -3.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersADMTRPMBSX
Held by institutions – 86.1% 90.5%
Institutions holding – 797 1,484
Change in shares held, QoQ – +3.8% -0.7%
Institutions buying – 386 738
Institutions selling – 245 612
Buyers to sellers – 1.58 1.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ADMTRPMBSX
ADMT 1.00 -0.03 0.14
RPM -0.03 1.00 0.08
BSX 0.14 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ADMT, RPM and BSX?

Boston Scientific (BSX) is the largest by market capitalisation: Adm Tronics Unlimited (ADMT) $6.93M, Rpm International (RPM) $13.19B, Boston Scientific (BSX) $62.89B.

Which stock is cheaper, ADMT, RPM and BSX?

Boston Scientific (BSX) trades on the lowest price-to-earnings ratio (Adm Tronics Unlimited (ADMT) -17.5x, Rpm International (RPM) 19.1x, Boston Scientific (BSX) 18.0x). On next year's consensus earnings, Boston Scientific (BSX) is cheapest (Rpm International (RPM) 18.9x, Boston Scientific (BSX) 14.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Boston Scientific (BSX) grew revenue fastest over the trailing twelve months: Adm Tronics Unlimited (ADMT) -2.2%, Rpm International (RPM) +6.0%, Boston Scientific (BSX) +8.9%.

Which company is more profitable?

Boston Scientific (BSX) has the highest net margin (Adm Tronics Unlimited (ADMT) -12.2%, Rpm International (RPM) 8.7%, Boston Scientific (BSX) 16.6%). On return on invested capital, Rpm International (RPM) leads (Adm Tronics Unlimited (ADMT) -27.1%, Rpm International (RPM) 12.5%, Boston Scientific (BSX) 9.9%).

Which stock has performed better?

Over the past year Adm Tronics Unlimited (ADMT) returned the most: Adm Tronics Unlimited (ADMT) 0.0%, Rpm International (RPM) -2.1%, Boston Scientific (BSX) -54.9%. Over five years, Rpm International (RPM) compounded fastest (Adm Tronics Unlimited (ADMT) -3.9%/yr, Rpm International (RPM) +3.2%/yr, Boston Scientific (BSX) +0.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Rpm International (RPM) has been the steadiest (Adm Tronics Unlimited (ADMT) 188.1%, Rpm International (RPM) 30.7%, Boston Scientific (BSX) 41.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ADMT, RPM and BSX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Boston Scientific (BSX) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.